Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 2.31% |
| 2 | Technology | 1.26% |
| 3 | Financials | 1.12% |
| 4 | Healthcare | 1.04% |
| 5 | Consumer Discretionary | 0.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2126
PUT
Take-Two Interactive
TTWO
$43.7B
| $5.41M | ﹤0.01% |
119,900
-15,200
| -11% | -$641K |
|
2127
PUT
Ubiquiti
UI
$36.1B
| $5.4M | ﹤0.01% |
101,000
-122,700
| -55% | -$5.89M |
|
2128
CALL
TE Connectivity
TEL
$59.4B
| $5.4M | ﹤0.01% |
83,900
-6,400
| -7% | -$391K |
|
|
EXPR
2129
PUT
DELISTED
Express, Inc.
EXPR
| $5.4M | ﹤0.01% |
22,905
+20,710
| +944% | +$5.61M |
|
2130
PUT
Cameco
CCJ
$46.8B
| $5.38M | ﹤0.01% |
628,400
+100,100
| +19% | +$963K |
|
2131
CALL
Rapid7
RPD
$795M
| $5.38M | ﹤0.01% |
304,700
+201,000
| +194% | +$3.14M |
|
2132
CALL
Ovintiv
OVV
$17.8B
| $5.38M | ﹤0.01% |
78,140
-82,740
| -51% | -$3.71M |
|
2133
iShares Core S&P Total US Stock Market ETF
ITOT
$97.1B
| $5.37M | ﹤0.01% |
108,426
-107,860
| -50% | -$5.32M |
|
2134
PUT
Sprouts Farmers Market
SFM
$8.1B
| $5.36M | ﹤0.01% |
259,500
+14,500
| +6% | +$322K |
|
2135
PUT
Shutterstock
SSTK
$205M
| $5.36M | ﹤0.01% |
84,100
+26,000
| +45% | +$1.49M |
|
|
SA
2136
PUT
Seabridge Gold
SA
$3.69B
| $5.36M | ﹤0.01% |
485,600
-240,800
| -33% | -$3.01M |
|
2137
CALL
Vornado Realty Trust
VNO
$7.27B
| $5.35M | ﹤0.01% |
65,437
+42,924
| +191% | +$3.56M |
|
2138
PUT
AGCO
AGCO
$7.81B
| $5.35M | ﹤0.01% |
108,500
+61,100
| +129% | +$2.93M |
|
|
LLL
2139
CALL
DELISTED
L3 Technologies, Inc.
LLL
| $5.35M | ﹤0.01% |
35,500
-9,100
| -20% | -$1.36M |
|
2140
CALL
iShares MSCI Canada ETF
EWC
$6.91B
| $5.35M | ﹤0.01% |
208,200
+12,300
| +6% | +$312K |
|
2141
CALL
Edison International
EIX
$28.7B
| $5.35M | ﹤0.01% |
74,000
+33,400
| +82% | +$2.51M |
|
2142
PUT
Natural Health Trends
NHTC
$14.7M
| $5.34M | ﹤0.01% |
189,100
-89,700
| -32% | -$2.78M |
|
|
TWO
2143
DELISTED
Two Harbors Investment
TWO
| $5.34M | ﹤0.01% |
78,253
+56,072
| +253% | +$3.95M |
|
|
CBPO
2144
CALL
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $5.34M | ﹤0.01% |
42,900
+19,100
| +80% | +$2.25M |
|
2145
CALL
Ultragenyx Pharmaceutical
RARE
$2.61B
| $5.33M | ﹤0.01% |
75,200
+5,800
| +8% | +$370K |
|
|
SVU
2146
CALL
DELISTED
SUPERVALU Inc.
SVU
| $5.33M | ﹤0.01% |
152,571
+87,585
| +135% | +$3.1M |
|
2147
CALL
Euronet Worldwide
EEFT
$2.64B
| $5.32M | ﹤0.01% |
65,000
+50,500
| +348% | +$3.87M |
|
2148
Papa John's
PZZA
$777M
| $5.31M | ﹤0.01% |
67,324
| – | – |
|
|
CIM
2149
Chimera Investment
CIM
$961M
| $5.3M | ﹤0.01% |
110,871
+66,510
| +150% | +$3.26M |
|
2150
CALL
TSMC
TSM
$2.17T
| $5.3M | ﹤0.01% |
173,400
-7,000
| -4% | -$200K |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass's Q3 2016 filing shows 1,347 new, 3,278 increased, 3,435 reduced and 1,488 closed positions. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M. The largest sale was Apple, an estimated $762M.
By sector, the portfolio is most concentrated in Consumer Staples at 2.3% of assets, up from 0.28% a quarter earlier, followed by Technology and Financials.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.